Literature DB >> 16957825

Prognostic factors in periampullary and pancreatic tumor resection in elderly patients.

R Casadei1, N Zanini, A M Morselli-Labate, L Calculli, R Pezzilli, O Potì, T Grottola, C Ricci, F Minni.   

Abstract

BACKGROUND: More than half of all patients with pancreatic adenocarcinoma are over 70 years of age. Life expectancy for the elderly population is increasing and currently major pancreatic resection provides the only meaningful chance of cure for periampullary and pancreatic tumors. Controversy over what constitutes the correct treatment of these tumors in elderly patients continues to this day. The aim of our study was to determine whether age alone or age plus some prognostic factors constitute contraindications to major pancreatic resections.
METHODS: Between 2000 and 2005, data from 88 consecutive patients who had major pancreatic resection for periampullary or pancreatic tumors were entered into a prospective database. Fifty-three patients under 70 years of age (young patients), and 35 patients 70 years of age or older (elderly patients) were compared with respect to several characteristics and the postoperative course.
RESULTS: Postoperative mortality and morbidity, length of hospital stay, and long-term survival were similar in the two groups. In the elderly group, the mortality rate was significantly higher in patients with chronic obstructive pulmonary disease (COPD), and the morbidity rate was significantly higher in patients with ASA 3 than in patients with ASA 1-2, in whom a pancreaticoduodenectomy or total pancreatectomy had been performed.
CONCLUSIONS: Age alone is not a contraindication for major pancreatic resection. In elderly patients a careful evaluation of the co-morbidities and of the type of surgical procedure is mandatory in order to allow the proper selection of those patients best suited for surgery in specialized centers.

Entities:  

Mesh:

Year:  2006        PMID: 16957825     DOI: 10.1007/s00268-006-0122-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  32 in total

Review 1.  Cancer in the elderly: pancreatic cancer.

Authors:  Susannah Shore; Dale Vimalachandran; Michael G T Raraty; Paula Ghaneh
Journal:  Surg Oncol       Date:  2004-12       Impact factor: 3.279

Review 2.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

3.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04

4.  Is age a risk factor for major pancreatic surgery? An analysis of 300 resections.

Authors:  T C Bottger; R Engelmann; T Junginger
Journal:  Hepatogastroenterology       Date:  1999 Jul-Aug

Review 5.  Current standards of surgery for pancreatic cancer.

Authors:  N Alexakis; C Halloran; M Raraty; P Ghaneh; R Sutton; J P Neoptolemos
Journal:  Br J Surg       Date:  2004-11       Impact factor: 6.939

6.  Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.

Authors:  Axel Richter; Marco Niedergethmann; Jörg W Sturm; Dietmar Lorenz; Stefan Post; Michael Trede
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

7.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

Authors:  S Pedrazzoli; V DiCarlo; R Dionigi; F Mosca; P Pederzoli; C Pasquali; G Klöppel; K Dhaene; F Michelassi
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

8.  A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy.

Authors:  C J Yeo; J L Cameron; M M Maher; P K Sauter; M L Zahurak; M A Talamini; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

9.  Pancreatic or liver resection for malignancy is safe and effective for the elderly.

Authors:  Y Fong; L H Blumgart; J G Fortner; M F Brennan
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

10.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more
  15 in total

1.  Surgical results of pancreatoduodenectomy in elderly patients.

Authors:  Shinichiro Yamada; Mitsuo Shimada; Tohru Utsunomiya; Yuji Morine; Satoru Imura; Tetsuya Ikemoto; Hiroki Mori; Mami Kanamoto; Jun Hanaoka; Shuichi Iwahashi; Yu Saitoh
Journal:  Surg Today       Date:  2012-03-24       Impact factor: 2.549

2.  Laparoscopic versus open distal pancreatectomy in pancreatic tumours: a case-control study.

Authors:  Riccardo Casadei; Claudio Ricci; Marielda D'Ambra; Nicola Marrano; Vincento Alagna; Daniela Rega; Francesco Monari; Francesco Minni
Journal:  Updates Surg       Date:  2010-12

3.  Is age a barrier to pancreaticoduodenectomy? An Italian dual-institution study.

Authors:  Riccardo Casadei; Giovanni Taffurelli; Stefano Silvestri; Claudio Ricci; Donata Campra; Francesco Minni
Journal:  Updates Surg       Date:  2015-11-27

4.  Surgical palliation of unresectable pancreatic head cancer in elderly patients.

Authors:  Sang Il Hwang; Hyung Ook Kim; Byung Ho Son; Chang Hak Yoo; Hungdai Kim; Jun Ho Shin
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

5.  Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series.

Authors:  Riccardo Casadei; Claudio Ricci; Raffaele Pezzilli; Davide Campana; Paola Tomassetti; Lucia Calculli; Donatella Santini; Nicola Antonacci; Francesco Minni
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 6.  Advanced age is a risk factor for post-operative complications and mortality after a pancreaticoduodenectomy: a meta-analysis and systematic review.

Authors:  Prashant Sukharamwala; Sukharamwala Prashant; Jonathan Thoens; Thoens Jonathan; Mauricio Szuchmacher; Szuchmacher Mauricio; James Smith; Smith James; Peter DeVito; DeVito Peter
Journal:  HPB (Oxford)       Date:  2012-06-27       Impact factor: 3.647

7.  Pancreatic cancer in the USA: persistence of undertreatment and poor outcome.

Authors:  Lindsey Enewold; Linda C Harlan; Thomas Tucker; Shaun McKenzie
Journal:  J Gastrointest Cancer       Date:  2015-03

8.  Clinical outcomes of pancreaticoduodenectomy in octogenarians: a surgeon's experience from 2007 to 2015.

Authors:  Diana H Liang; Beverly A Shirkey; Wade R Rosenberg; Sylvia Martinez
Journal:  J Gastrointest Oncol       Date:  2016-08

9.  Do not deny pancreatic resection to elderly patients.

Authors:  Roberto Ballarin; Mario Spaggiari; Fabrizio Di Benedetto; Roberto Montalti; Michele Masetti; Nicola De Ruvo; Antonio Romano; Gian Piero Guerrini; Maria Grazia De Blasiis; Giorgio Enrico Gerunda
Journal:  J Gastrointest Surg       Date:  2008-09-11       Impact factor: 3.452

Review 10.  [Pancreatic cancer in the elderly: guidelines and individualized therapy].

Authors:  H Nieß; A Kleespies; J Andrassy; S Pratschke; P Pratschke; M K Angele; M Guba; K-W Jauch; C J Bruns
Journal:  Chirurg       Date:  2013-04       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.